GE Instruments – The truth is in your hands.

Our civilisation is very restrictive. In my opinion it comes from attempts to control others and the most powerful way to do it, is to limit access to what humans want and need. We all need and want to have sex and money. Sexual drive is a deeply seeded survival instinct and not using or... Read more

GE Healthcare, Elekta Collaborate to Expand Access to Precision Radiation Therapy Solutions

Chicago/Stockholm: April 5, 2022 – GE Healthcare and Elekta (EKTA-B.ST) announced today that they have signed a global commercial collaboration agreement in the field of radiation oncology, enabling the two companies to provide hospitals a comprehensive offering across imaging and treatment for cancer patients requiring radiation therapy. As hospitals increasingly seek flexible and interoperable simulation... Read more

GE Healthcare Receives FDA Approval of First-Ever Software to Help Automate Anesthesia Delivery and Reduce Greenhouse Gas Emissions During Surgery

CHICAGO – April 4, 2022 – GE Healthcare announced today the FDA pre-market approval (PMA) for its End-tidal (Et) Control software for general anesthesia delivery on its Aisys CS2Anesthesia Delivery System. GE Healthcare is the only manufacturer approved to offer general anesthesia delivery with end-tidal concentration control in the U.S. The company initially released the... Read more

GE Healthcare and Leading Korean Hospital Aim to Accelerate AI Ecosystem Using GE’s New Edison Digital Health Platform

Seoul National University Bundang Hospital to leverage GE Healthcare’s artificial intelligence (AI) capabilities to take the lead in using medical AI in their hospital system. The two collaborators intend to support and accelerate Korean start-ups to test and develop clinical applications on Edison Digital Health Platform Seoul, South Korea – March 31, 2022 — GE... Read more

GE Healthcare announces first patient dosed in phase III clinical trial for new dopamine transporter imaging radiopharmaceutical

First patient dosed in Phase III clinical trial for PET radiopharmaceutical Next stage clinical study also proceeding for SPECT radiopharmaceutical Both imaging agents aim to assist in the evaluation of adult patients with suspected Parkinsonian syndromes, support research and improve patient care Builds on market leadership with SPECT agent DaTscan™ (Ioflupane I 123 Injection), to... Read more

GE Healthcare, AliveCor Partnership Aims to Increase Convenience for Patients and Help Reduce Cardiac-Related Hospitalizations by Improving the Quality and Integration of Patient Data

Physicians accessing GE Healthcare’s MUSE, a cardiac management system that connects to and integrates into the electronic medical record (EMR), can now view and interpret in MUSE ECGs taken by patients using AliveCor’s KardiaMobile 6L personal ECG device, strengthening the care continuum from hospital into the home, or anytime, anywhere. Used by 87 percent of... Read more

GE Healthcare Developing a Digital Health Platform to Help Providers Accelerate Digital Transformation

GE Healthcare announced its intention to bring to market, a digital health platform to be called Edison Digital Health Platform.     GE Healthcare is recruiting healthcare providers and ecosystem participants to help evaluate the platform in a production setting. A digital health platform is seen as a cost-effective and technically efficient way to speed the... Read more

European Society of Radiology and GE Healthcare renew their strategic partnership for ECR 2022

Vienna, Austria – February 21, 2022 – The European Society of Radiology (ESR) and GE Healthcare announce today the renewal of their partnership for the online European Congress of Radiology (ECR Overture) on March 2-6, 2022, and onsite ECR 2022 on July 13-17 in Vienna, Austria. The partnership includes a complete 2,000m² new area and... Read more